BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30008050)

  • 1. Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa.
    Larsen A; Cheyip M; Tesfay A; Vranken P; Fomundam H; Wutoh A; Aynalem G
    AIDS Behav; 2019 Feb; 23(2):375-385. PubMed ID: 30008050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
    Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
    BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
    Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
    J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lost to follow up rate in the first year of ART in adults initiated in a universal test and treat programme: a retrospective cohort study in Ekurhuleni District, South Africa.
    Chauke P; Huma M; Madiba S
    Pan Afr Med J; 2020; 37():198. PubMed ID: 33505567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
    PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
    Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
    Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
    Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
    J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of antiretroviral therapy initiation in eThekwini (Durban), South Africa: Findings from a prospective cohort study.
    Sy KTL; Tariq S; Ramjee G; Blanchard K; Leu CS; Kelvin EA; Exner TM; Gandhi AD; Lince-Deroche N; Mantell JE; O'Sullivan LF; Hoffman S
    PLoS One; 2021; 16(2):e0246744. PubMed ID: 33606712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
    Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
    J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
    Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
    J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
    Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
    Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
    Bassett IV; Regan S; Chetty S; Giddy J; Uhler LM; Holst H; Ross D; Katz JN; Walensky RP; Freedberg KA; Losina E
    AIDS; 2010 Jan; 24 Suppl 1(Suppl 1):S37-44. PubMed ID: 20023438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis.
    Yapa HM; Kim HY; Petoumenos K; Post FA; Jiamsakul A; De Neve JW; Tanser F; Iwuji C; Baisley K; Shahmanesh M; Pillay D; Siedner MJ; Bärnighausen T; Bor J
    Clin Infect Dis; 2022 Apr; 74(8):1350-1359. PubMed ID: 34309633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.
    Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Orne-Gliemann J; Pillay D; Dabis F;
    J Int AIDS Soc; 2019 Oct; 22(10):e25402. PubMed ID: 31637821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
    Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
    Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini.
    Kerschberger B; Jobanputra K; Schomaker M; Kabore SM; Teck R; Mabhena E; Lukhele N; Rusch B; Boulle A; Ciglenecki I
    J Int AIDS Soc; 2019 Oct; 22(10):e25401. PubMed ID: 31647613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2016; 28 Suppl 1(sup1):114-8. PubMed ID: 26922939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda.
    Mugenyi L; Hansen CH; Mayaud P; Seeley J; Newton R; Nanfuka M; Abaasa A; Mugisha K; Etukoit M; Kaleebu P; Ruzagira E
    Front Public Health; 2023; 11():1187274. PubMed ID: 37361157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivating people living with HIV to initiate antiretroviral treatment outside national guidelines in three clinics in the HPTN 071 (PopART) trial, South Africa.
    Mubekapi-Musadaidzwa C; Wademan D; Peton N; Hendricks P; Carolus G; Mbaezue R; Kelley KF; Kruger J; Jennings K; Grobbelaar N; Louis F; Beyers N; Ayles H; Fidler S; Hayes R; Bock P; Hoddinott G
    Afr J AIDS Res; 2021 Mar; 20(1):32-41. PubMed ID: 33635735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.